Recruiting A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies NCT05908409 Conditions Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more Locations Hospital Universitario Marques de Valdecilla — Santander, Cantabria, Spain Hospital Universitario de Salamanca — Salamanca, Castille and León, Spain Hospital Universitari Vall d'hebron — Barcelona, Spain Hospital Durán i Reynals - ICO L´Hospitalet — Barcelona, Spain View more locations Show fewer locations Loading locations... View Trial Details
